Accessibility Menu
Vitrolife Ab (publ) logo

Vitrolife Ab (publ)

(OTC) VTRLY

Current Price$11.04
Market Cap$1.50B
Since IPO (2016)-4%
5 Year-55%
1 Year-25%
1 Month+0%

Vitrolife Ab (publ) Financials at a Glance

Market Cap

$1.50B

Revenue (TTM)

SEK 3.39B

Net Income (TTM)

-SEK 5.01B

EPS (TTM)

-$3.93

P/E Ratio

-2.81

Dividend

$0.12

Beta (Volatility)

0.07 (Low)

Price

$11.04

Volume

300

Open

$11.04

Previous Close

$11.04

Daily Range

$11.04 - $11.04

52-Week Range

$9.50 - $18.55

Estimated Earnings Date

Apr 22, 2026

VTRLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vitrolife Ab (publ)

Industry

Biotechnology

Employees

1,126

CEO

Bronwyn Brophy O'Connor

Headquarters

Gothenburg, 421 32, SE

VTRLY Financials

Key Financial Metrics (TTM)

Gross Margin

51.41%

Operating Margin

18.04%

Net Income Margin

-147.21%

Return on Equity

-47.11%

Return on Capital

6.10%

Return on Assets

-44.57%

Earnings Yield

-35.59%

Dividend Yield

1.07%

Payout Ratio

-2.97%

Stock Overview

Market Cap

$1.50B

Shares Outstanding

135.42M

Volume

300

Avg. Volume

10.016

Financials (TTM)

Gross Profit

SEK 1.92B

Operating Income

-SEK 4.83B

EBITDA

-SEK 4.66B

Operating Cash Flow

SEK 731.80M

Capital Expenditure

-SEK 184.79M

Free Cash Flow

SEK 557.19M

Cash & ST Invst.

SEK 886.00M

Total Debt

SEK 1.58B

Vitrolife Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 807.00M

-4.2%

Gross Profit

SEK 483.00M

+0.0%

Gross Margin

59.85%

N/A

Market Cap

$1.50B

N/A

Market Cap/Employee

$1.30M

N/A

Employees

1,150

N/A

Net Income

SEK 101.00M

+1.0%

EBITDA

SEK 209.00M

+39.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 886.00M

-15.9%

Total Debt

SEK 1.58B

-18.9%

Accounts Receivable

SEK 802.00M

+7.5%

Inventory

SEK 428.00M

+3.6%

Long Term Debt

SEK 1.54B

-14.7%

Short Term Debt

SEK 91.75M

-39.2%

Return on Assets

-44.57%

N/A

Return on Invested Capital

5.77%

N/A

Free Cash Flow

SEK 132.66M

+92.3%

Operating Cash Flow

SEK 178.26M

+158.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNNDYGN Store Nord A/S
$40.62+1.02%
HTSUFHisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%
BRCTFBioArctic AB (publ)
$35.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$18.15+0.00%
TAT&T
$20.48-0.01%
SOFISoFi Technologies
$18.44+0.03%
NUNu Holdings
$13.39+0.00%

Questions About VTRLY

What is the current price of Vitrolife Ab (publ)?

Vitrolife Ab (publ) is trading at $11.04 per share.

What is the 52-week range for Vitrolife Ab (publ)?

Over the past 52 weeks, Vitrolife Ab (publ) has traded between $9.50 and $18.55.

How much debt does Vitrolife Ab (publ) have?

As of the most recent reporting period, Vitrolife Ab (publ) reported total debt of SEK 166.07M.

How much cash does Vitrolife Ab (publ) have on hand?

Vitrolife Ab (publ) reported SEK 93.01M in cash and cash equivalents in its most recent financial results.

What is Vitrolife Ab (publ)’s dividend yield?

Vitrolife Ab (publ) currently has a dividend yield of 1.07%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.